| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
More...
| ||||||||||||||||||||||||||||||||||||
| << Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >> | ||||||||||||||||||||||||||||||||||||
| Results 1 - 17 of 1441 | ||||||||||||||||||||||||||||||||||||
More
-
Glaxo to double China R&D staff in few years
SHANGHAI (Reuters) - GlaxoSmithKline, the world's second-largest drugmaker, plans to double its research and development staff in China to 350 people in the next few years, an executive said on Tuesday.
-
EnerSys Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common...
EnerSys announced today the pricing of $150 million aggregate principal amount of its convertible senior notes due 2038 and 3,400,000 shares of its common stock offered by certain of its stockholders.